AC-104

N/A

Report date: 2023/02/09 18:30:53

Base Information

Drug NameAC-104

Drug Alias NameAC104

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAnti-Vascular endothelial growth factorAnti-Vascular endothelial growth factor receptor 2

TargetsVascular endothelial growth factorVascular endothelial growth factor receptor 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbclon Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAbclon Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A